Biotech · Private company
Santhera Pharmaceuticals
Track this companyFree. Adds Santhera Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- IdebenonePhase 3 · Friedreich's AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
- idebenone 150 mg film-coated tabletsPhase 3 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Idebenone 150 mg film-coated tabletsPhase 3 · Duchenne Muscular Dystrophy (DMD)ClinicalTrials.gov · fetched Nov 12, 2026
- OmigapilPhase 1 · Congenital Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- IdebenoneDuchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- IdebenoneLeber's Hereditary Optic Neuropathy (LHON)ClinicalTrials.gov · fetched Nov 12, 2026
- VamoroloneDuchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)PHASE2 · COMPLETED · started Jul 7, 2022ClinicalTrials.gov NCT05166109 · fetched Nov 12, 2026
- Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)PHASE3 · TERMINATED · started Jul 4, 2018ClinicalTrials.gov NCT03603288 · fetched Nov 12, 2026
- A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid SteroidsPHASE3 · TERMINATED · started Sep 1, 2016ClinicalTrials.gov NCT02814019 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of Raxone in LHON PatientsPHASE4 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02774005 · fetched Nov 12, 2026
- Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)PHASE1 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT01805024 · fetched Nov 12, 2026
- Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia PatientsPHASE3 · COMPLETED · started Jul 1, 2008ClinicalTrials.gov NCT00697073 · fetched Nov 12, 2026
- Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's AtaxiaPHASE3 · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00537680 · fetched Nov 12, 2026
- Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)NO_LONGER_AVAILABLEClinicalTrials.gov NCT03433807 · fetched Nov 12, 2026
- Expanded Access Protocol for Boys With Duchenne Muscular DystrophyAVAILABLEClinicalTrials.gov NCT03863119 · fetched Nov 12, 2026